Volumetry: An alternative to assess therapy response for malignant pleural mesothelioma?

European Respiratory Journal

Volumn 38, Issue 1, 2011, Pages 162-168

  Frauenfelder, T ^a   Tutic, M ^a   Weder, W ^a   Gotti R P ^a   Stahel, R A ^a   Seifert, B ^b   Opitz, I ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Computed tomography; Induction chemotherapy; Malignant pleural mesothelioma; Response evaluation criteria in solid tumours; Therapy response; Volumetry

Indexed keywords

CISPLATIN; GEMCITABINE; IODIXANOL; PEMETREXED;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLASSIFICATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; MALE; MALIGNANT PLEURAL MESOTHELIOMA; MULTIPLE CYCLE TREATMENT; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; VOLUMETRY;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MEDICAL ONCOLOGY; MESOTHELIOMA; MIDDLE AGED; OBSERVER VARIATION; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; PULMONARY MEDICINE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79960181364     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00146110     Document Type: Article

References (18)

1. Weder W, Stahel R, Bernhard J, et al. Multicenter trial of neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007; 18: 1196-1202. (Pubitemid 47244366)
2. Pass HI, Temeck BK, Kranda K, et al. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1998; 115: 310-317.
3. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214. (Pubitemid 11167383)
4. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
5. Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004; 15: 257-260. (Pubitemid 38262625)
6. Armato SG 3rd., Oxnard GR., MacMahon H., et al. Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. Med Phys 2004; 31: 1105-1115. (Pubitemid 38656781)
7. Oxnard GR, Armato SG 3rd., Kindler HL. Modeling of mesothelioma growth demonstrates weaknesses of current response criteria. Lung Cancer 2006; 52: 141-148.
8. Winer-Muram HT, Jennings SG, Meyer CA, et al. Effect of varying CT section width on volumetric measurement of lung tumors and application of compensatory equations. Radiology 2003; 229: 184-194. (Pubitemid 37152123)
9. Graser A, Becker CR, Reiser MF, et al. [Volumetry of metastases from renal cell carcinoma: comparison with the RECIST criteria]. Radiologe 2008; 48: 850-856.
10. Bolte H, Riedel C, Knoss N, et al. Computed tomography-based lung nodule volumetry - do optimized reconstructions of routine protocols achieve similar accuracy, reproducibility and interobserver variability to that of special volumetry protocols? Rofo 2007; 179: 276-281.
11. Lemke AJ, Brinkmann MJ, Schott T, et al. Living donor right liver lobes: preoperative CT volumetric measurement for calculation of intraoperative weight and volume. Radiology 2006; 240: 736-742. (Pubitemid 44267329)
12. Reiner CS, Karlo C, Petrowsky H, et al. Preoperative liver volumetry: how does the slice thickness influence the multidetector computed tomography- and magnetic resonance-liver volume measurements? J Comput Assist Tomogr, 2009; 33: 390-397.
13. Ak G, Metintas M, Metintas S, et al. Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma. Eur J Radiol 2010; 74: 130-135.
14. Plathow C, Klopp M, Thieke C, et al. Therapy response in malignant pleural mesothelioma - role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT. Eur Radiol 2008; 18: 1635-1643.
15. 18F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol 2010; 17: 2787-2794.
16. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174. (Pubitemid 8054849)
17. Rousson V, Gasser T, Seifert B. Assessing intrarater, interrater and test-retest reliability of continuous measurements. Stat Med 2002; 21: 3431-3446. (Pubitemid 35314660)
18. Metintas M, Ucgun I, Elbek O, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 2002; 41: 1-9. (Pubitemid 34002983)